Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, manufacture, and commercialization of novel pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers.
Location: United States, Florida, Tampa
Employees: 501-1000
Total raised: $11.25M
Founded date: 2006
Investors 2
| Date | Name | Website |
| - | Hercules C... | htgc.com |
| - | HBM Partne... | hbmpartner... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.05.2010 | - | $11.25M | - |
Mentions in press and media 13
| Date | Title | Description |
| 10.05.2024 | Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029 | - |
| 08.05.2024 | Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes | - |
| 13.03.2024 | Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee | - |
| 06.03.2024 | Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference | - |
| 05.01.2023 | Pacira BioSciences Reports Preliminary Unaudited Total Revenue for 2022 of $666.8 Million | TAMPA, Fla., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. PCRX, the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported preliminary unaudited total revenue of $666.... |
| 09.12.2021 | Pacira BioSciences : Announces Closing of $375 Million Five-Year Term Loan B - Form 8-K | Pacira BioSciences Announces Closing of $375 Million Five-Year Term Loan B -- Provides additional operational and financial flexibility -- -- Underscores strength of forecasted earnings and operating cash flow -- TAMPA, FL, December 9, 2021... |
| 28.08.2020 | Startups To Watch: CapWay, Mozper, Copper Banking, Yotta Savings, PrizePool, Syntegra, Avalon.Ai, PitchMe | 19 Shares Email Facebook Twitter LinkedIn Crunchbase News typically covers larger funding rounds, however we think these startups are worth highlighting for their interesting approaches despite their smaller raises. Subscribe to the Crunchb... |
| 05.03.2019 | Pacira Pharmaceuticals acquires med device company MyoScience in deal worth up to $220M | No drugs, opioids or narcotics are used as part of the treatment, which can last up to 90 days before the nerve regenerates. iovera will be added to Pacira’s existing pain management portfolio, which includes Exparel, a bupivacaine-based tr... |
| 25.10.2017 | Pacira Pharmaceuticals and TELA Bio Announce Equity Agreement | Pacira to invest up to $25 million in TELA Bio to enhance commercial and clinical initiatives for distinct class of novel surgical implants for soft tissue repair PARSIPPANY, N.J. and MALVERN, Pa., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Pacira ... |
| 11.05.2010 | Pacira Pharmaceuticals Receives $11.25M Credit Facility from GE Capital | Pacira Pharmaceuticals, Inc., a San Diego, CA-based acute care specialty pharmaceutical company with a primary focus on formulating, developing and manufacturing sustained-release, injectable products, has received an $11.25m credit facilit... |
Show more